Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: May 13, 2008
Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in , DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution.
Released: April 25, 2008
Planning for an influenza pandemic, whether it occurs in the near or distant future, will need to take into account many constantly evolving factors. The Institute of Medicine (IOM) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic was asked by the Department of Health and Human Services, (DHHS) to consider best practices and policies for providing antiviral treatment and prophylaxis during a pandemic event.
Released: April 22, 2008
Standardizing Medication Labels: Confusing Patients Less is the summary of a workshop, held in , D.C. on October 12, 2007, that was organized to examine what is known about how medication container labeling affects patient safety and to discuss approaches to addressing identified problems.
Released: April 11, 2008
The Institute of Medicine charged the ad hoc Committee on the Future Health Care Workforce for Older Americans to determine the health care needs of Americans over 65 years of age and to assess those needs through an analysis of the forces that shape the health care workforce, including education and training, models of care, and public and private programs. The resulting report, Retooling for an Aging America: Building the Health Care Workforce, says that as the population of seniors grows to comprise approximately 20 percent of the U.S. population, they will face a health care workforce that is too small and critically unprepared to meet their health needs.
Released: April 09, 2008
In April 2007, the Institute of Medicine’s Forum on Drug Discovery, Development, and Translation convened a workshop entitled “Emerging Safety Science” to examine the use of emerging safety science technologies in drug development and to consider their application in the drug review process. This publication summarizes the presentations and discussions during that workshop.
Released: April 07, 2008
The Institute of Medicine’s Forum on the Science of Health Care Quality Improvement and Implementation convened a workshop in , D.C. entitled, Creating a Business Case for Quality Improvement and Quality Improvement Research. The overall goal of the workshop was to develop a better understanding of the economic and business disciplines that encourage sustained efforts to improve the quality of health care.
Released: March 25, 2008
The Institute of Medicine’s Food and Nutrition Board and the National Research Council’s Policy and Global Affairs Division convened a workshop in , D.C., entitled Foodborne Disease and Public Health An Iranian-U.S. Workshop.
Released: March 20, 2008
The 2007 Rosenthal Lecture featured a panel talk on Transforming Today’s Health Care Workforce to Meet Tomorrow’s Demands
Released: March 18, 2008
The Institute of Medicine’s Forum on Microbial Threats convened a workshop—on June 19-20, 2007, in Ft. Collins, CO—entitled Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. The purpose of this public workshop was to examine the global burden of vector-borne diseases of humans, animals, and plants, and to discuss prospects for successful mitigation and response strategies.
Released: March 05, 2008
A lack of information about Vietnam veterans’ level of exposure to Agent Orange or other herbicides has been a fundamental challenge in past studies evaluating whether veterans’ health problems might be linked to herbicide exposure during the war. A new Institute of Medicine report, The Utility of Proximity-Based Herbicide Exposure Assessment in Epidemiologic Studies of Vietnam Veterans, presents the conclusions and recommendations of a committee that was convened to provide guidance to the Department of Veterans Affairs about the best use of an exposure assessment model that was developed to address this problem.